Cannabix Technologies Inc. (BLO.CN)
| Previous Close | 0.3400 |
| Open | 0.3500 |
| Bid | 0.3850 x 0 |
| Ask | 0.3950 x 0 |
| Day's Range | 0.3400 - 0.4400 |
| 52 Week Range | 0.1600 - 0.4400 |
| Volume | |
| Avg. Volume | 49,751 |
| Market Cap | 45.087M |
| Beta (5Y Monthly) | 2.26 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0300 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports that it will be presenting at the International Association for Chemical Testing (IACT) conference in April. Cannabix’s Dr
GlobeNewswireCannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix
Cannabix has developed an autonomous alcohol breathalyzer screening device for employersVANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices reports that it has shipped its Industrial Series Contactless Alcohol Breathalyzers (“CAB” devices) for certification testing and is rebranding the “CAB” name under the new “Breath Logix” p
- GlobeNewswire
Cannabix Technologies Welcomes Dr. Phillip Olla to the Board of Directors
VANCOUVER, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that Dr. Phillip Olla (Ph.D.) has joined the board of directors. Dr. Olla is an expert in breath technologies, breathomics, healthcare innovation, artificial and medical informatics. Dr. Olla has served as the CEO of Audacia Bioscience, a health informatics company who per
